Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis
Objective There is no coordinated cascade testing program for familial hypercholesterolemia (FH) in the U.S. We evaluated the contemporary cost-effectiveness of cascade genetic testing relatives of FH probands with a pathogenic variant. Methods: A simulation model was created to simulate multiple fa...
Saved in:
Main Authors: | Candace L. Jackson (Author), Todd Huschka (Author), Bijan Borah (Author), Katherine Agre (Author), Magdi Zordok (Author), Medhat Farwati (Author), James Moriarty (Author), Iftikhar J. Kullo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Familial hypercholesterolemia in Southeast and East Asia
by: Candace L. Jackson, et al.
Published: (2021) -
The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
by: Seyedmohammad Saadatagah, et al.
Published: (2022) -
A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model
by: Mary P. McGowan, et al.
Published: (2021) -
Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
by: Gemme Campbell-Salome, et al.
Published: (2023) -
Association between smoking cessation and post-hospitalization healthcare costs: a matched cohort analysis
by: Margaret B. Nolan, et al.
Published: (2019)